Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
July 21, 2026
First US Patient Randomized in Pivotal Trial of i-Lumen's Bioelectric Therapy for Dry AMD
July 20, 2026
Adverum Reports 5-year OPTIC Extension Data for Investigational Gene Therapy for Wet AMD
Data Presented at ASRS Support Real-World Safety, Efficacy of Byooviz Biosimilar SB11
July 17, 2026
Inflammasome Therapeutics Reports Positive Phase 2 Data for K8 in Geographic Atrophy
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
